头孢曲松钠-杂质A

头孢曲松钠-杂质A性质、用途与生产工艺

头孢曲松钠-杂质A 上下游产品信息

上游原料

下游产品

头孢曲松钠-杂质A 生产厂家

92143-31-2, 头孢曲松钠-杂质A 相关搜索:

• Sulfur & Selenium Compounds
• Pharmaceuticals
• Intermediates & Fine Chemicals
• Heterocycles
• 123-头孢曲松钠
• 头孢曲松杂质
• 杂质对照品
• 头孢曲松钠
• 头孢曲松EP杂质A(头孢曲松钠杂质A对照品)
• 头孢曲松钠 USP 有关杂质 H
• (6R,7R)-7-((E)-2-(2-氨基噻唑-4-基)-2-(甲氧基亚氨基)乙酰氨基)-3-(((2-甲基-5,6-二氧代-1,2,5,6-四氢-1,2,4-三嗪-3-基)硫代)甲基)-8-氧代-5-噻-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 (头孢曲松杂质)
• 头孢曲松A
• 头孢曲松酯杂质A
• CEFTRIAXONE EP杂质 A
• (E)-头孢曲松
• 头孢曲松钠杂质01
• 头孢曲松EP杂质A
• 头孢曲松EP杂质A(E)
• 原料药头孢曲松钠 杂质A
• 92143-31-2
• (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid:triethylamine(5:3)
• Ceftriaxone EP Impurity A Monomer
• Nicotinamide Impurity 240
• (6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Ceftriaxone Impurity)
• Ceftriaxone Sodium USP Impurity H
• Ceftriaxone Impurity 1 Monomer((E)-Ceftriaxone Monomer)(Ceftriaxone EP Impurity A Monomer)
• Ceftriaxone EP Impurity AQ: What is Ceftriaxone EP Impurity A Q: What is the CAS Number of Ceftriaxone EP Impurity A Q: What is the storage condition of Ceftriaxone EP Impurity A Q: What are the applications of Ceftriaxone EP Impurity A
• (E)-Ceftriaxone Ceftriaxone Impurity A
• (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, (6R,7R)-
• Ceftriaxone sodium impurity 01
• Ceftriaxone impurity 1/Ceftriaxone EP Impurity A/(E)-Ceftriaxone/(6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• Ceftriaxone impurity 1/Ceftriaxone EP Impurity A/(E)-Ceftriaxone/(6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbo
• Ceftriaxone Impurity A(E)
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2E)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-,(6R,7R)- (9CI)
• Ceftriaxone EP Impurity A ((E)-Ceftriaxone)
• Ceftriaxone Impurity 1(Ceftriaxone EP Impurity A)((E)-Ceftriaxone)
• Ceftriaxone EP Impurity A
• (E)-Ceftriaxone
• (6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5, 6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• Ro 15-2254
• (6R,7R)-7-[[(2E)-2-(2-AMino-4-thiazolyl)-2-(MethoxyiMino)acetyl]aMino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-Methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]Methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid